Noori T et al., 2023-11: Iranian mouse study in the cuprizone demyelination model finding both ivermectin and ivermectin-loaded nanoparticles reduced demyelination and improved behavioural measures.
The results evidenced that IVM and nano-IVM administration is capable of reducing demyelination in mice.
Noori T et al., 2023-11: Iranian mouse study in the cuprizone demyelination model finding both ivermectin and ivermectin-loaded nanoparticles reduced demyelination and improved behavioural measures. Animal study, four groups of 7 male C57BL/6 mice (control, cuprizone, ivermectin, nano-ivermectin), Iran; demyelination induced with 0.2% cuprizone for 6 weeks; ivermectin and nano-ivermectin 1 mg/kg/day intraperitoneally for the last 14 days. Comparator: cuprizone-only and normal-diet controls. Declared conflicts: none. Evidence level: animal model, small groups (n=7), intraperitoneal route not used in humans. Study type: animal.
